Ricevi le ultime notizie sulle azioni Galectin Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di GALT

Ultime notizie per

GALECTIN THERAPEUTICS INC

Galectin Therapeutics

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.

Galectin Therapeutics Inc. - Common Stock

Galectin Therapeutics Inc

Earnings

Press Releases

Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update

News

Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2025 Congress

Health Care

Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2025 and Provides Business Update

Galectin Therapeutics to Host Virtual KOL Event to Discuss Belapectin for Treatment of MASH Cirrhosis and Portal Hypertension

Small Cap

Opinion

Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is Going

Financing

Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update

Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Galectin Therapeutics to Present at the American Association for the Study of Liver Disease (AASLD) Liver Meeting 2025

CATX

CGON

GALT

ONCY

PRPH

TSX:ONC

Abeona Therapeutics

Aldeyra Therapeutics, Inc. - Common Stock

Aldeyra Therapeutics

Alector

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Annexon

Candel Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Fennec Pharmaceuticals Inc. - Common Stock

Fennec Pharmaceuticals

Humacyte

Immutep Limited - American Depositary Shares

Immutep

Invivyd

Lyell Immunopharma

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group

Neurogene

Puma Biotechnology

PepGen

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

Tenaya Therapeutics

Vanda Pharmaceuticals Inc. - Common Stock

Vanda Pharmaceuticals

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics

Zura Bio Limited - Class A Ordinary shares

Comments

Galectin Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO